Prepare for the Clinical Genetics Test. Utilize flashcards and multiple-choice questions, each with hints and explanations. Achieve success on your exam!

Multiple Choice

In Lynch syndrome gynecologic risk management may include risk-reducing surgery.

In Lynch syndrome, the risk of gynecologic cancers (especially endometrial and ovarian) is markedly elevated, so preventive strategies focus on substantial risk reduction rather than relying on surveillance alone. Prophylactic surgery that removes both the uterus and the ovaries (hysterectomy with bilateral salpingo-oophorectomy) dramatically lowers the chances of developing these cancers and is the most effective preventive measure. This option is typically considered after childbearing is complete and the patient is at an appropriate age, balancing cancer risk with the consequences of early menopause and hormone management. Surveillance methods like regular imaging or endometrial sampling do not prevent cancer and thus cannot replace preventive surgery. Chemoprevention alone is not a standard, sufficient strategy, and saying there’s no specific gynecologic risk management undervalues the high cancer risk in this population.

In Lynch syndrome, the risk of gynecologic cancers (especially endometrial and ovarian) is markedly elevated, so preventive strategies focus on substantial risk reduction rather than relying on surveillance alone. Prophylactic surgery that removes both the uterus and the ovaries (hysterectomy with bilateral salpingo-oophorectomy) dramatically lowers the chances of developing these cancers and is the most effective preventive measure. This option is typically considered after childbearing is complete and the patient is at an appropriate age, balancing cancer risk with the consequences of early menopause and hormone management. Surveillance methods like regular imaging or endometrial sampling do not prevent cancer and thus cannot replace preventive surgery. Chemoprevention alone is not a standard, sufficient strategy, and saying there’s no specific gynecologic risk management undervalues the high cancer risk in this population.